ImmunOs Therapeutics AG, a spin-off of the University of Zurich and University of Basel, is leading the discovery and development of the next generation of novel human immunomodulatory proteins for cancer treatment that not only have direct anti-tumor effects but also remodel the tumor microenvironment and enhance the efficacy of existing immunotherapies. The team has extensive expertise in the field of drug development and g...
ImmunOs Therapeutics AG, a spin-off of the University of Zurich and University of Basel, is leading the discovery and development of the next generation of novel human immunomodulatory proteins for cancer treatment that not only have direct anti-tumor effects but also remodel the tumor microenvironment and enhance the efficacy of existing immunotherapies. The team has extensive expertise in the field of drug development and global commercialization in immunotherapy, immunology, and oncology. Our mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.